Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis

Abstract Background Medication consumption has been suggested as a risk factor for microscopic colitis (MC), but studies of varying design have yielded inconsistent results. Our aim was to evaluate the association between medications and MC. Methods A hybrid cohort of prospectively identified patien...

Full description

Bibliographic Details
Main Authors: Eugene F. Yen, Daniel B. Amusin, Janet Yoo, Asantewaa Ture, Nicole M. Gentile, Michael J. Goldberg, Jay L. Goldstein
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-022-02438-z
_version_ 1811222159954018304
author Eugene F. Yen
Daniel B. Amusin
Janet Yoo
Asantewaa Ture
Nicole M. Gentile
Michael J. Goldberg
Jay L. Goldstein
author_facet Eugene F. Yen
Daniel B. Amusin
Janet Yoo
Asantewaa Ture
Nicole M. Gentile
Michael J. Goldberg
Jay L. Goldstein
author_sort Eugene F. Yen
collection DOAJ
description Abstract Background Medication consumption has been suggested as a risk factor for microscopic colitis (MC), but studies of varying design have yielded inconsistent results. Our aim was to evaluate the association between medications and MC. Methods A hybrid cohort of prospectively identified patients undergoing colonoscopy with biopsies for suspicion of MC (N = 144) and patients with MC enrolled within three months of diagnosis into an MC registry (N = 59) were surveyed on medication use. Medication use was compared between patients with and without diagnosis of MC by chi-squared test and binomial logistic regression adjusted for known risk factors of MC: age and gender. Results In total, 80 patients with MC (21 new, 59 registry) were enrolled. Patients with MC were more likely to be older (p = 0.03) and female (p = 0.01) compared to those without MC. Aspirin and other non-steroidal anti-inflammatory drugs were more commonly used among patients who developed MC (p < 0.01). After controlling for age and gender, these medications remained independent predictors of MC with odds ratio for any non-steroidal anti-inflammatory drug use of 3.04 (95% CI: 1.65–5.69). No association between MC and other previously implicated medications including proton pump inhibitors and selective serotonin reuptake inhibitors was found. Conclusions In this cohort of patients with chronic diarrhea, we found use of aspirin and non-steroidal anti-inflammatory drugs, but not other implicated medications to be associated with the development of MC. Whether these drugs trigger colonic inflammation in predisposed hosts or worsen diarrhea in undiagnosed patients is unclear. However, we feel that these findings are sufficient to discuss potential non-steroidal anti-inflammatory drug cessation in patients newly diagnosed with MC.
first_indexed 2024-04-12T08:11:40Z
format Article
id doaj.art-e294c166196b406881edeb3230f77f32
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-04-12T08:11:40Z
publishDate 2022-07-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-e294c166196b406881edeb3230f77f322022-12-22T03:40:58ZengBMCBMC Gastroenterology1471-230X2022-07-012211810.1186/s12876-022-02438-zNonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitisEugene F. Yen0Daniel B. Amusin1Janet Yoo2Asantewaa Ture3Nicole M. Gentile4Michael J. Goldberg5Jay L. Goldstein6Division of Gastroenterology, NorthShore University HealthSystemDivision of Gastroenterology, NorthShore University HealthSystemRush University College of NursingNorthwestern University Feinberg School of MedicineDivision of Gastroenterology, NorthShore University HealthSystemDivision of Gastroenterology, NorthShore University HealthSystemDivision of Gastroenterology, NorthShore University HealthSystemAbstract Background Medication consumption has been suggested as a risk factor for microscopic colitis (MC), but studies of varying design have yielded inconsistent results. Our aim was to evaluate the association between medications and MC. Methods A hybrid cohort of prospectively identified patients undergoing colonoscopy with biopsies for suspicion of MC (N = 144) and patients with MC enrolled within three months of diagnosis into an MC registry (N = 59) were surveyed on medication use. Medication use was compared between patients with and without diagnosis of MC by chi-squared test and binomial logistic regression adjusted for known risk factors of MC: age and gender. Results In total, 80 patients with MC (21 new, 59 registry) were enrolled. Patients with MC were more likely to be older (p = 0.03) and female (p = 0.01) compared to those without MC. Aspirin and other non-steroidal anti-inflammatory drugs were more commonly used among patients who developed MC (p < 0.01). After controlling for age and gender, these medications remained independent predictors of MC with odds ratio for any non-steroidal anti-inflammatory drug use of 3.04 (95% CI: 1.65–5.69). No association between MC and other previously implicated medications including proton pump inhibitors and selective serotonin reuptake inhibitors was found. Conclusions In this cohort of patients with chronic diarrhea, we found use of aspirin and non-steroidal anti-inflammatory drugs, but not other implicated medications to be associated with the development of MC. Whether these drugs trigger colonic inflammation in predisposed hosts or worsen diarrhea in undiagnosed patients is unclear. However, we feel that these findings are sufficient to discuss potential non-steroidal anti-inflammatory drug cessation in patients newly diagnosed with MC.https://doi.org/10.1186/s12876-022-02438-zMicroscopic colitisCollagenous colitisLymphocytic colitisNon-steroidal anti-inflammatory drugs
spellingShingle Eugene F. Yen
Daniel B. Amusin
Janet Yoo
Asantewaa Ture
Nicole M. Gentile
Michael J. Goldberg
Jay L. Goldstein
Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
BMC Gastroenterology
Microscopic colitis
Collagenous colitis
Lymphocytic colitis
Non-steroidal anti-inflammatory drugs
title Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
title_full Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
title_fullStr Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
title_full_unstemmed Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
title_short Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
title_sort nonsteroidal anti inflammatory drug exposure and the risk of microscopic colitis
topic Microscopic colitis
Collagenous colitis
Lymphocytic colitis
Non-steroidal anti-inflammatory drugs
url https://doi.org/10.1186/s12876-022-02438-z
work_keys_str_mv AT eugenefyen nonsteroidalantiinflammatorydrugexposureandtheriskofmicroscopiccolitis
AT danielbamusin nonsteroidalantiinflammatorydrugexposureandtheriskofmicroscopiccolitis
AT janetyoo nonsteroidalantiinflammatorydrugexposureandtheriskofmicroscopiccolitis
AT asantewaature nonsteroidalantiinflammatorydrugexposureandtheriskofmicroscopiccolitis
AT nicolemgentile nonsteroidalantiinflammatorydrugexposureandtheriskofmicroscopiccolitis
AT michaeljgoldberg nonsteroidalantiinflammatorydrugexposureandtheriskofmicroscopiccolitis
AT jaylgoldstein nonsteroidalantiinflammatorydrugexposureandtheriskofmicroscopiccolitis